MENU
+Compare
UTHR
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$358.93
Change
-$7.46 (-2.04%)
Capitalization
16.02B

UTHR United Therapeutics Corp Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

Industry Biotechnology
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for UTHR with price predictions
Jan 14, 2025

UTHR in -1.02% downward trend, falling for three consecutive days on January 13, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where UTHR declined for three days, in of 267 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Aroon Indicator for UTHR entered a downward trend on December 23, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 14, 2025. You may want to consider a long position or call options on UTHR as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for UTHR just turned positive on January 08, 2025. Looking at past instances where UTHR's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UTHR advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UTHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.627) is normal, around the industry mean (14.746). P/E Ratio (15.770) is within average values for comparable stocks, (87.786). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (1.852). UTHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (6.365) is also within normal values, averaging (263.573).

View a ticker or compare two or three
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

UTHR is expected to report earnings to rise 4.54% to $6.68 per share on February 19

United Therapeutics Corp UTHR Stock Earnings Reports
Q4'24
Est.
$6.68
Q3'24
Missed
by $0.14
Q2'24
Missed
by $0.63
Q1'24
Beat
by $0.38
Q4'23
Missed
by $0.08
The last earnings report on October 30 showed earnings per share of $6.39, missing the estimate of $6.53. With 248.35K shares outstanding, the current market capitalization sits at 16.02B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

UTHR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with HALO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then HALO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-2.04%
HALO - UTHR
34%
Loosely correlated
-1.03%
TGTX - UTHR
32%
Poorly correlated
+1.41%
INCY - UTHR
32%
Poorly correlated
-0.75%
IONS - UTHR
31%
Poorly correlated
-2.63%
MNKD - UTHR
28%
Poorly correlated
N/A
More